New Biosimilars Issue Brief Shows Massive State and Taxpayer Savings Possible by Expanding Biosimilars Market
October 2, 2019
Briefs, Industry Trends, Innovation, Price and Costs, Resources
Biosimilars have the opportunity to bring significant savings to state Medicaid programs and consumers with commercial insurance according to a new study released today by Pacific Research Institute. “Every state would experience significant savings in the state Medicaid programs from expanding the use of biosimilars compared to the more expensive originator biologics,” said Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation and author of the new issue brief on biosimilars. “The same benefits will also accrue to...